The Financial Times jumps feet first into the Life Extension fray today…
http://www.ft.com/intl/cms/s/0/9ed80e14-dd11-11e4-a772-00144feab7de.html#axzz3WwzQ9er7
It is a somewhat shallow article concerning the potential depth that could have been explored.
I found the following of interest…
“…Bridge Two, when the biotechnology revolution will reprogramme our inherited biology”, and “Bridge Three”: molecular nanotechnology enabling us to rebuild our bodies.
…where Ray discusses how he envisions staying alive long enough for the science to reach the point where living forever is within reach.
What is disconcerting is hearing how much it costs for his daily pills. A good example of how the benefits of Life Extension may become only available to those wealthy enough to afford it.
Leave a Reply